These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37569661)

  • 1. New Highly Selective BACE1 Inhibitors and Their Effects on Dendritic Spine Density In Vivo.
    Pratsch K; Unemura C; Ito M; Lichtenthaler SF; Horiguchi N; Herms J
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6.
    Zhu K; Xiang X; Filser S; Marinković P; Dorostkar MM; Crux S; Neumann U; Shimshek DR; Rammes G; Haass C; Lichtenthaler SF; Gunnersen JM; Herms J
    Biol Psychiatry; 2018 Mar; 83(5):428-437. PubMed ID: 28129943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE inhibitor treatment of mice induces hyperactivity in a Seizure-related gene 6 family dependent manner without altering learning and memory.
    Nash A; Gijsen HJM; Hrupka BJ; Teng KS; Lichtenthaler SF; Takeshima H; Gunnersen JM; Munro KM
    Sci Rep; 2021 Jul; 11(1):15084. PubMed ID: 34302009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons.
    Pigoni M; Wanngren J; Kuhn PH; Munro KM; Gunnersen JM; Takeshima H; Feederle R; Voytyuk I; De Strooper B; Levasseur MD; Hrupka BJ; Müller SA; Lichtenthaler SF
    Mol Neurodegener; 2016 Oct; 11(1):67. PubMed ID: 27716410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions.
    Filser S; Ovsepian SV; Masana M; Blazquez-Llorca L; Brandt Elvang A; Volbracht C; Müller MB; Jung CK; Herms J
    Biol Psychiatry; 2015 Apr; 77(8):729-39. PubMed ID: 25599931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2).
    Li S; Zhao H; Li J; Hao J; Yu H
    J Biomol Struct Dyn; 2021 May; 39(8):2824-2837. PubMed ID: 32276567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational BACE inhibitors for the treatment of Alzheimer's disease.
    Imbimbo BP; Watling M
    Expert Opin Investig Drugs; 2019 Nov; 28(11):967-975. PubMed ID: 31661331
    [No Abstract]   [Full Text] [Related]  

  • 8. Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System.
    Munro KM; Nash A; Pigoni M; Lichtenthaler SF; Gunnersen JM
    J Mol Neurosci; 2016 Nov; 60(3):305-315. PubMed ID: 27456313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function.
    Zhu K; Peters F; Filser S; Herms J
    Biol Psychiatry; 2018 Oct; 84(7):478-487. PubMed ID: 29945719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.
    Resende R; Ferreira-Marques M; Moreira P; Coimbra JRM; Baptista SJ; Isidoro C; Salvador JAR; Dinis TCP; Pereira CF; Santos AE
    J Alzheimers Dis; 2020; 76(4):1317-1337. PubMed ID: 32597812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.
    Vassar R; Kuhn PH; Haass C; Kennedy ME; Rajendran L; Wong PC; Lichtenthaler SF
    J Neurochem; 2014 Jul; 130(1):4-28. PubMed ID: 24646365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.
    Shi XP; Tugusheva K; Bruce JE; Lucka A; Wu GX; Chen-Dodson E; Price E; Li Y; Xu M; Huang Q; Sardana MK; Hazuda DJ
    J Biol Chem; 2003 Jun; 278(23):21286-94. PubMed ID: 12665519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines.
    Blume T; Filser S; Jaworska A; Blain JF; Koenig G; Moschke K; Lichtenthaler SF; Herms J
    Front Aging Neurosci; 2018; 10():229. PubMed ID: 30093858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
    Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
    Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice.
    Eketjäll S; Janson J; Jeppsson F; Svanhagen A; Kolmodin K; Gustavsson S; Radesäter AC; Eliason K; Briem S; Appelkvist P; Niva C; Berg AL; Karlström S; Swahn BM; Fälting J
    J Neurosci; 2013 Jun; 33(24):10075-84. PubMed ID: 23761903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS.
    Georgievska B; Gustavsson S; Lundkvist J; Neelissen J; Eketjäll S; Ramberg V; Bueters T; Agerman K; Juréus A; Svensson S; Berg S; Fälting J; Lendahl U
    J Neurochem; 2015 Feb; 132(4):477-86. PubMed ID: 25156639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-ß plaque formation and BACE1 accumulation in the brains of a 5xFAD Alzheimer's disease mouse model is associated with altered distribution and not proteolysis of BACE1 substrates Sez6 and Sez6L.
    Dominko K; Rastija A; Smiljanic K; Mladenovic A; Lešnjaković L; Kanazir S; Milanovic D; Hecimovic S
    Mech Ageing Dev; 2022 Oct; 207():111726. PubMed ID: 35998821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE1 and BACE2 enzymatic activities in Alzheimer's disease.
    Ahmed RR; Holler CJ; Webb RL; Li F; Beckett TL; Murphy MP
    J Neurochem; 2010 Feb; 112(4):1045-53. PubMed ID: 19968762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β-Secretase BACE1 in Alzheimer's Disease.
    Hampel H; Vassar R; De Strooper B; Hardy J; Willem M; Singh N; Zhou J; Yan R; Vanmechelen E; De Vos A; Nisticò R; Corbo M; Imbimbo BP; Streffer J; Voytyuk I; Timmers M; Tahami Monfared AA; Irizarry M; Albala B; Koyama A; Watanabe N; Kimura T; Yarenis L; Lista S; Kramer L; Vergallo A
    Biol Psychiatry; 2021 Apr; 89(8):745-756. PubMed ID: 32223911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.